Pharmacy providers resources
Resources
Alberta pharmacies
A Reference guide for administering and claiming outreach vaccines 2024/2025
Reference Guide for the 2024-2025 Alberta Influenza Immunization Program
AlbertaQuits Pharmacy Claims Reference Guide
Critical Supply Product List (PDF) | (Excel)
Nutritional Product, Package Size, and UPC Listing (PDF) | (Excel)
Alberta Blue Cross® Guide to Step Therapy
Alberta Blue Cross® Standard Maximum Allowable Cost (MAC) Drugs and Reference Price Listing
ASEBP TARP Drugs and Reference Price Listing
ASEBP member FAQs regarding TARP policy
Frequent Dispensing Policy Q&As
Maintenance Medication Program Drug Listing
Pharmacist Prescriber Special Authorization Registration Form
Healthcare Professionals Guide – May 1, 2024
Patient Information Sheet – November 1, 2024
Patient Supports – July 1, 2025
Addition of denosumab biosimilars – all adult patients on Prolia must switch by May 1, 2025 – November 1, 2024
Addition of ustekinumab biosimilars – all adult patients on Stelara must switch by November 1, 2024 – May 1, 2024
Addition of tocilizumab biosimilars – all adult patients on Actemra must switch by January 1, 2026 – July 1, 2025
Summary table of drugs in Biosimilar Initiative – July 1, 2025